Splenectomy and thrombosis: the case of thalassemia intermedia
Tài liệu tham khảo
Weatherall, 2001
Sturgeon, 1955, Genetic and biochemical studies of intermediate types of Cooley’s anaemia, Br J Haematol, 1, 264, 10.1111/j.1365-2141.1955.tb05509.x
Taher, 2010, Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study, Blood, 115, 1886, 10.1182/blood-2009-09-243154
Borgna Pignatti, 1998, Thromboembolic events in beta thalassemia major: an Italian multicenter study, Acta Haematol, 99, 76, 10.1159/000040814
Taher, 2006, Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran, Thromb Haemost, 96, 488, 10.1160/TH06-05-0267
Crary, 2009, Vascular complications after splenectomy for hematologic disorders, Blood, 114, 2861, 10.1182/blood-2009-04-210112
Camaschella, 1995, Thalassemia intermedia, Haematologica, 80, 58
Barst, 2004, Diagnosis and differential assessment of pulmonary arterial hypertension, J Am Coll Cardiol, 43, 40S, 10.1016/j.jacc.2004.02.032
Kleber, 1992, Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial, Br Heart J, 67, 289, 10.1136/hrt.67.4.289
Nathan, 2009, Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes, Diabetes Care, 32, 193, 10.2337/dc08-9025
Shinar, 1989, Differing erythrocyte membrane skeletal protein defects in alpha and beta thalassemia, J Clin Invest, 83, 404, 10.1172/JCI113898
Hershko, 1978, Non‐specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity, Br J Haematol, 40, 255, 10.1111/j.1365-2141.1978.tb03662.x
Tavazzi, 2001, Membrane‐bound iron contributes to oxidative damage of beta‐thalassaemia intermedia erythrocytes, Br J Haematol, 112, 48, 10.1046/j.1365-2141.2001.02482.x
Borenstain‐Ben Yashar, 1993, Phosphatidylserine in the outer leaflet of red blood cells from beta‐thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes, Am J Hematol, 44, 63, 10.1002/ajh.2830440114
Helley, 1996, Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta‐thalassemia, Thromb Haemost, 76, 322, 10.1055/s-0038-1650577
Atichartakarn, 2002, Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/beta‐thalassaemic patients, Br J Haematol, 118, 893, 10.1046/j.1365-2141.2002.03711.x
Habib, 2008, Elevated levels of circulating procoagulant microparticles in patients with beta‐thalassemia intermedia, Haematologica, 93, 941, 10.3324/haematol.12460
Aessopos, 2007, Thalassemia intermedia today: should patients regularly receive transfusions?, Transfusion, 47, 792, 10.1111/j.1537-2995.2007.01192.x
Pippard, 1988, Iron balance and the management of iron overload in beta‐thalassemia intermedia, Birth Defects Orig Artic Ser, 23, 29
Pootrakul, 2003, Clinical trial of deferiprone iron chelation therapy in beta‐thalassaemia/haemoglobin E patients in Thailand, Br J Haematol, 122, 305, 10.1046/j.1365-2141.2003.04412.x
Voskaridou, 2010, Treatment with deferasirox (Exjade) effectively decreases iron burden in patients with thalassaemia intermedia: results of a pilot study, Br J Haematol, 148, 332, 10.1111/j.1365-2141.2009.07930.x
Del Principe, 1993, PADGEM/GMP‐140 expression on platelet membranes from homozygous beta thalassaemic patients, Br J Haematol, 84, 111, 10.1111/j.1365-2141.1993.tb03033.x
Ruf, 1997, In‐vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta‐thalassaemia major, Br J Haematol, 98, 51, 10.1046/j.1365-2141.1997.1502965.x
Eldor, 1991, In vivo platelet activation in beta‐thalassemia major reflected by increased platelet‐thromboxane urinary metabolites, Blood, 77, 1749, 10.1182/blood.V77.8.1749.1749
Cappellini, 2005, Coagulation and splenectomy: an overview, Ann N Y Acad Sci, 1054, 317, 10.1196/annals.1345.039
Gladwin, 2008, Pulmonary complications of sickle cell disease, N Engl J Med, 359, 2254, 10.1056/NEJMra0804411
Isma’eel, 2008, Relation between iron‐overload indices, cardiac echo‐Doppler, and biochemical markers in thalassemia intermedia, Am J Cardiol, 102, 363, 10.1016/j.amjcard.2008.03.066
O’Donnell, 2007, Age‐related changes in adaptation to severe anemia in childhood in developing countries, Proc Natl Acad Sci USA, 104, 9440, 10.1073/pnas.0703424104
Aessopos, 2001, Cardiac involvement in thalassemia intermedia: a multicenter study, Blood, 97, 3411, 10.1182/blood.V97.11.3411
Aessopos, 2005, Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia, Chest, 127, 1523, 10.1378/chest.127.5.1523